PTC

Medtech companies are facing rapid changes in global regulations, from FDA updates to new EU MDR requirements. In this clip, industry experts discuss the growing complexity, regulatory volatility, and why the focus is shifting from simple compliance to quality and patient outcomes.

Watch to learn:
1. What’s driving regulatory uncertainty in medtech
2. How FDA and EU MDR changes affect product launches
3. Why quality and patient outcomes matter more than ever